Shallow WGS of individual CTCs identifies actionable targets for

By A Mystery Man Writer

DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma, Genome Medicine

Detection of circulating cell-free HPV DNA of 13 HPV types for

Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer

Frontiers Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy

a, b Correlation of ESR1 mutation with the number of hormone

Frontiers Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review

Cell‐free circulating tumour DNA as a liquid biopsy in breast cancer - De Mattos‐Arruda - 2016 - Molecular Oncology - Wiley Online Library

A Targeted Q-PCR-Based Method for Point Mutation Testing by

PDF) A Rapid, Shallow Whole Genome Sequencing Workflow Applicable

Untargeted profiling of cell-free circulating DNA - Zhou - Translational Cancer Research

©2016-2024, doctommy.com, Inc. or its affiliates